Literature DB >> 3496684

A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC).

D C Briggs, P T Donaldson, P Hayes, K I Welsh, R Williams, J M Neuberger.   

Abstract

Primary Biliary Cirrhosis (PBC) is a female associated disease of unknown aetiology, although there is evidence of immunological abnormalities. There is no known cure; liver damage is progressive and eventually fatal, although transplantation can prevent patient death. Data presented here show, for the first time, a strong association in Caucasoids between PBC and the major histocompatibility complex (MHC). 45% of patients studied, compared with only 17% in a control group, expressed an MHC Class III allotype C4B 2 (pc = 0.014). Polymorphisms of MHC Class I, Class II, and other Class III gene products which flank the C4 genes were not found to be associated with the disease. Although we cannot rule out the involvement of other loci linked to the C4B 2 complement gene, the data provide strong evidence that this genetic area is implicated in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496684     DOI: 10.1111/j.1399-0039.1987.tb01566.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

Review 1.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Genetics and genomics of primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

Review 3.  Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Authors:  Pietro Invernizzi
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

4.  Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.

Authors:  G Rittner; G Schwanitz; M P Baur; C M Black; K I Welsh; P Kühnl; C Rittner
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

Review 5.  Prevalence and pattern of familial disease in primary biliary cirrhosis.

Authors:  A M Brind; G P Bray; B C Portmann; R Williams
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

6.  Chromosomal aberrations in patients with primary biliary cirrhosis.

Authors:  A Notghi; U Nestle; G Rittner; P Brissot; H Jouanolle; M Manns; E Schleiermacher; C Rittner
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility.

Authors:  P Donaldson; K Agarwal; A Craggs; W Craig; O James; D Jones
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Genomic variants associated with primary biliary cirrhosis.

Authors:  Carlo Selmi; Natalie J Torok; Andrea Affronti; M Eric Gershwin
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

9.  DNA polymorphism of HLA class II genes in primary biliary cirrhosis.

Authors:  N Morling; K Dalhoff; L Fugger; J Georgsen; B Jakobsen; L Ranek; N Odum; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 10.  Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis.

Authors:  Baodong Qin; Jiaqi Wang; Jia Chen; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.